Conference abstract · 2019
Conference abstract
Cancer nanotechnology: Roadmap to clinical translation of gold mediated therapeutics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recent developments in nanotechnology has provided new tools for cancer therapy and diagnosis. Among other nanomaterial systems, gold nanoparticles are being used as radiation dose enhancers and anticancer drug carriers. Our studies show that size, shape, and surface properties of NPs can play a major role in their interaction with tumor cells. We have a developed a comprehensive research platform which includes monolayer cell models, multilayer cell models (tissue like models), and in vivo animal models to test the therapeutic efficacy of gold mediated sensitization. It is important to test NP formulations at all three above mentioned levels to optimize their use in future clinical applications. For example, our previous work at monolayer level showed that NPs of diameter 50 nm had the highest cell uptake among the size range 10-100 nm. However, at tissue-level NPs of diameter lower than 50 nm showed the highest tissue penetration. Once these NPs leave the tumor blood vessels, it important that they should be able to penetrate tumor tissue deeper. Hence, we used smaller NPs for our in vivo studies. We were able to achieve more than 12% of the NP formulation within the tumor. We have also shown for the first time that cancer drug loaded gold nanoparticles can reach the nucleus (or the brain) of cancer cells enhancing the therapeutic effect dramatically. Nucleus of the cancer cells are the most desirable target in cancer therapy. In chemotherapy, smart delivery of highly toxic anticancer drugs through packaging using nanoparticles will reduce the side effects and improve the quality and care of cancer patients. In radiation therapy, use of gold nanoparticles as radiation dose enhancer is very promising due to enhanced localized dose within the cancer tissue. PDF HTML Awards Nomination 0.329+ Million Readerbase
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Mini review · 28 Nov 2023
Integrating Biomarkers into Clinical Practice: A Roadmap for Effective Cancer Management
Editorial · 30 Dec 2025
Clinical Translation, Drug Carriers, and the Therapeutic Index
Short communication · 20 Dec 2023
Advancing Therapeutics through Clinical Trials and Translational Medicine
Conference abstract · 18 Jul 2018
NanoBindi- Unified precision therapeutic platform for translating lead candidates to early clinical assets in oncology
More from this journal
The newest in American Journal of Advanced Drug Delivery.
Article · 18 Jan 2025
Nose to Brain Drug Delivery System
Article · 30 Dec 2024
Protein and Peptide Drug Delivery: Challenges and Innovations
Article · 30 Dec 2024
Process Design and Optimization of Drug Delivery Systems
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAmerican Journal of Advanced Drug Delivery
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Devika Chithrani”
